Association between Toll-Like Receptor Gene Cluster (TLR6, TLR1, and TLR10) and Prostate Cancer

Background: Chronic inflammation may be a risk factor for prostate cancer. Previously, we found significant associations between single nucleotide polymorphisms (SNPs) and haplotypes in Toll-like receptor (TLR) 4 and the risk of prostate cancer. TLR6, TLR1, and TLR10 are also involved in the pathogen-mediated inflammation pathway. A Swedish study observed associations between sequence variants in the TLR6-TLR1-TLR10 gene cluster and the risk of prostate cancer. We assessed if genetic polymorphisms of this gene cluster were associated with the risk of prostate cancer in a U.S. population. Methods: In a nested case-control design within the Health Professionals Follow-Up Study, we identified 700 participants with prostate cancer who were diagnosed after they had provided a blood specimen in 1993 and by January 31, 2000. Controls were 700 age-matched men without prostate cancer who had had a prostate-specific antigen test. We genotyped 19 common (>5%) haplotype-tagging SNPs chosen from the SNPs discovered in a resequencing study spanning TLR6, TLR1, and TLR10 to test for the association between sequence variants cluster and prostate cancer. Results: Neither individual SNPs nor common haplotypes in the three gene regions were associated with altered risk of prostate cancer or subgroups of aggressive prostate cancer. No effect modification was observed for age, body mass index, or family history of prostate cancer, except that TLR6_3649 showed nominally significant interaction with family history at the P < 0.05 level. Conclusion: Inherited sequence variants of the innate immune gene cluster TLR6-TLR1-TLR10 were not appreciably associated with the risk of prostate cancer in this cohort. (Cancer Epidemiol Biomarkers Prev 2007;16(10):1982–9)

[1]  T. Awata,et al.  Porcine Toll-like receptor 1, 6, and 10 genes: complete sequencing of genomic region and expression analysis. , 2006, Molecular immunology.

[2]  H. Grönberg,et al.  Interactions of Sequence Variants in Interleukin-1 Receptor–Associated Kinase4 and the Toll-Like Receptor 6-1-10 Gene Cluster Increase Prostate Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[3]  D. Hunter,et al.  Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. , 2005, Cancer research.

[4]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[5]  W. Willett,et al.  Sex Steroid Hormones and the Androgen Receptor Gene CAG Repeat and Subsequent Risk of Prostate Cancer in the Prostate-Specific Antigen Era , 2005, Cancer Epidemiology Biomarkers & Prevention.

[6]  H. Grönberg,et al.  Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. , 2005, Journal of the National Cancer Institute.

[7]  A. Sodhi,et al.  Involvement of TLR6/1 in rLcrV-mediated immunomodulation of murine peritoneal macrophages in vitro. , 2005, Molecular immunology.

[8]  G. Trinchieri,et al.  Human TLR10 Is a Functional Receptor, Expressed by B Cells and Plasmacytoid Dendritic Cells, Which Activates Gene Transcription through MyD881 , 2005, The Journal of Immunology.

[9]  E. Silverman,et al.  TOLL-like receptor 10 genetic variation is associated with asthma in two independent samples. , 2004, American journal of respiratory and critical care medicine.

[10]  L. Kinlen.  Infections and immune factors in cancer: the role of epidemiology , 2004, Oncogene.

[11]  J. Vlach,et al.  Differential induction of gene promoter constructs by constitutively active human TLRs. , 2004, Biochemical and biophysical research communications.

[12]  M. Daly,et al.  Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. , 2004, Diabetes.

[13]  H. Grönberg,et al.  Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. , 2004, Cancer research.

[14]  M. Abreu,et al.  Innate immunity and toll-like receptors: clinical implications of basic science research. , 2004, The Journal of pediatrics.

[15]  S. Gabriel,et al.  Assessing the impact of population stratification on genetic association studies , 2004, Nature Genetics.

[16]  Liwu Li,et al.  Regulation of innate immunity signaling and its connection with human diseases. , 2004, Current drug targets. Inflammation and allergy.

[17]  A. Neugut,et al.  The "skinny" on obesity and prostate cancer prognosis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  E. Platz,et al.  Epidemiology of inflammation and prostate cancer. , 2004, The Journal of urology.

[19]  E. Giovannucci.  Nutrition, Insulin, Insulin-like Growth Factors and Cancer , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[20]  Daniel O. Stram,et al.  Modeling and E-M Estimation of Haplotype-Specific Relative Risks from Genotype Data for a Case-Control Study of Unrelated Individuals , 2003, Human Heredity.

[21]  S. Janssens,et al.  Role of Toll-Like Receptors in Pathogen Recognition , 2003, Clinical Microbiology Reviews.

[22]  E. Rimm,et al.  Body mass index and risk of prostate cancer in U.S. health professionals. , 2003, Journal of the National Cancer Institute.

[23]  Paola Sebastiani,et al.  Minimal haplotype tagging , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Esmon,et al.  Bench-to-bedside review: Functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis , 2002, Critical care.

[25]  S. Akira,et al.  Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins1 , 2002, The Journal of Immunology.

[26]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[27]  Peter H. Westfall,et al.  Testing Association of Statistically Inferred Haplotypes with Discrete and Continuous Traits in Samples of Unrelated Individuals , 2002, Human Heredity.

[28]  T. Giese,et al.  Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1 , 2002, The Journal of Immunology.

[29]  G. Hansson,et al.  Expression of Toll-Like Receptors in Human Atherosclerotic Lesions: A Possible Pathway for Plaque Activation , 2002, Circulation.

[30]  S. Dower,et al.  Regulation of Toll-Like Receptors in Human Monocytes and Dendritic Cells1 , 2001, The Journal of Immunology.

[31]  A. Aderem,et al.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  L A Kalish,et al.  Family history and the risk of prostate cancer. , 2000, Urology.

[33]  S. Akira,et al.  TLR6: A novel member of an expanding toll-like receptor family. , 1999, Gene.

[34]  P. Ernst,et al.  Review article: the role of inflammation in the pathogenesis of gastric cancer , 1999, Alimentary pharmacology & therapeutics.

[35]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[36]  V. Macaulay,et al.  Insulin-like growth factors and cancer. , 1992, British Journal of Cancer.

[37]  W. Willett,et al.  Test of the National Death Index. , 1984, American journal of epidemiology.

[38]  L. M. Franks,et al.  Etiology, epidemiology, and pathology of prostatic cancer , 1973 .

[39]  J. Cerhan,et al.  Family history and prostate cancer risk in a population-based cohort of Iowa men. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[40]  T H Beaty,et al.  Family history and the risk of prostate cancer , 1990, The Prostate.

[41]  B. Hølund.  Latent prostatic cancer in a consecutive autopsy series. , 1980, Scandinavian journal of urology and nephrology.

[42]  L. M. Franks.  Proceedings: Etiology, epidemiology, and pathology of prostatic cancer. , 1973, Cancer.